Advertisement
Screener

Surrozen, Inc./DE (SRZN) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Surrozen, Inc./DE Cash Flow Breakdown

Cash flow breakdown shows where Surrozen, Inc./DE's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $30.24M went out.
  • Fiscal year ended 2025-12-31: from investing, $128.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $85.05M came in.
  • Fiscal year ended 2025-12-31: change in cash, $54.68M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksNew shares soldNot split outChange in cash
2025-12-31-$30.24M-$128.00K$74.70M$10.35M*$54.68M
2024-12-31-$17.63M-$26.00K$16.04M-$1.48M
2023-12-31-$40.36M$51.72M$0.00$0.00$11.64M
2022-12-31-$44.15M$38.31M-$2.61M$0.00-$8.40M
2021-12-31-$48.81M-$77.71M$0.00$124.22M-$1.89M
2020-12-31-$29.10M-$15.07M$0.00$50.05M*$5.88M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$7.42M*-$19.00K*$0.00*$2.51M*
2026-03-31-$12.49M-$120.00K$0.00$30.28M*$17.66M
2025-12-31-$5.81M*-$59.00K*$3.50M*$10.28M*
2025-09-30-$9.04M*-$24.00K*$0.00*
2025-06-30-$6.11M*-$18.00K*-$5.18M*
2025-03-31-$9.28M-$27.00K$76.39M$67.08M
2024-12-31$3.48M*-$19.00K*$0.00*
2024-09-30-$6.75M*$0.00*-$1.00K*
2024-06-30-$5.61M*$0.00*$16.04M*
2024-03-31-$8.75M-$7.00K$0.00-$8.75M
2023-12-31-$7.31M*$9.50M*$0.00*
2023-09-30-$10.13M*$7.65M*$0.00*
2023-06-30-$8.75M*$17.25M*
2023-03-31-$14.17M$17.33M$3.12M
2022-12-31-$205.00K*$1.91M*$0.00*-$2.55M*
2022-09-30-$14.15M*$22.83M*$0.00*
2022-06-30-$11.41M*$13.98M*$0.00*
2022-03-31-$18.37M-$412.00K$0.00-$18.79M
2021-12-31-$11.54M*-$16.62M*$125.00K*
2021-09-30-$14.06M*-$68.28M*$72.00K*$124.52M*
2021-06-30-$12.88M*$8.64M*$109.00K*
2021-03-31-$10.33M-$1.44M$196.00K-$11.58M
2020-12-31-$9.34M*-$14.66M*$0.00*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Zura Bio Ltd (ZURA)$0.398B-6.56
AGENUS INC (AGEN)United States$0.383B1.41
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Eikon Therapeutics, Inc. (EIKN)United States$0.446B